Arzneimittelrabattvertrag zu den Arzneimitteln Advate (B02BD02),Recombinate (B02BD02),Rixubis (B02BD04),Feiba (B02BD03),Immunate (B02BD06),Immuseven (B02BD05),Adynovi (B02BD02),Veyvondi (B02BD10)
Deadline:N/A
Contract award
Duration
01/09/2026 - 31/08/2028
Bidders
Awarded bidders
Name
Price
Takeda GmbH
